HAMPS BIO LIMITED · CashKonnect

About

Hamps Bio Limited engages in marketing and manufacturing of pharmaceutical, freeze-dried food, and nutraceutical ingredients in India and internationally. It operates through Pharma Products and Freeze-Dried Products segments. The company offers nutrition supplements, injection, pediatric care, toothpaste, mouth wash, antiacid/PPI, painkiller/anti-inflammatory, hematantic/calcium supplement, and antibiotic/antibacterial/antifungal pharmaceutical products. It also offers dry freeze food products, including ingredients for fruit tea / traditional tea, fruit snacks / juice powder, foods, and super food. The company sells its products under the HAMPS and FzyEzy brands through distribution network and e-commerce platform. Hamps Bio Limited was incorporated in 2007 and is based in Surat, India.

Quarterly Results

No quarterly results synced yet for this stock.

Data is backfilled from screener.in — check back soon.

Profit & Loss

Annual · Rs. Crores

Metric	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Sales	8.52	6.67	6.48	5.58	5.34
Expenses	8.41	5.90	5.31	4.71	4.72
Operating Profit	0.11	0.77	1.17	0.87	0.62
OPM %	1.29	11.54	18.06	15.59	11.61
Other Income	0.33	0.15	0.03	0.01	0.00
Interest	0.25	0.14	0.15	0.18	0.19
Depreciation	0.81	0.38	0.40	0.34	0.33
Profit before tax	-0.62	0.40	0.65	0.36	0.10
Tax %	6.45	25.00	23.08	0.00	-20.00
Net Profit	-0.65	0.30	0.50	0.36	0.12
EPS in Rs	-0.75	0.34	1.28	1.20	0.40
Dividend Payout %	0.00	0.00	0.00	0.00	0.00

Balance Sheet

Annual · Rs. Crores — latest first

Metric	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Equity Capital	8.71	4.36	1.96	1.50	1.50
Reserves	-0.53	4.44	1.38	-0.14	-0.49
Borrowings	6.40	2.97	1.05	1.74	2.04
Other Liabilities	0.65	1.02	0.73	0.86	0.60
Total Liabilities	15.23	12.79	5.12	3.96	3.65
Fixed Assets	7.19	2.48	2.52	2.61	2.15
CWIP	1.08	3.38	0.00	0.00	0.00
Investments	2.04	0.00	0.00	0.00	0.04
Other Assets	4.92	6.93	2.60	1.35	1.46
Total Assets	15.23	12.79	5.12	3.96	3.65

Cash Flows

Annual · Rs. Crores — latest first

Metric	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Cash from Operating Activity	-0.37	-1.76	-0.29	1.23	0.33
Cash from Investing Activity	-2.93	-6.21	-0.37	-0.75	0.51
Cash from Financing Activity	3.23	8.00	0.67	-0.48	-0.94
Net Cash Flow	-0.06	0.04	0.01	0.00	-0.10
Free Cash Flow	-3.59	-5.48	-0.65	0.44	0.87
CFO/OP %	-336.00	-214.00	-12.00	141.00	53.00

Ratios

Annual · Days / % — latest first

Metric	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Debtor Days	51.84	65.12	55.76	49.71	47.16
Inventory Days	296.87	452.45	264.09	75.03	94.57
Days Payable	41.37	114.06	60.12	103.42	63.05
Cash Conversion Cycle	307.34	403.51	259.73	21.32	78.69
Working Capital Days	60.83	128.05	55.20	-58.22	-34.86
ROCE %	-2.81	6.68	21.36	17.56	—